Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

GBCI, DLKM, BAGL, PWRM, ARRS - Stock Report From DrStockPick.com!

drstock-2-3

signup3m

dlkm_logo

Douglas Lake Minerals (OTCBB:DLKM) is pleased to announce that it has filed a Canadian National Instrument 43-101 Standards for Disclosure of Mineral Projects (”NI 43-101) Technical Report (the “Technical Report”) for its Handeni Project. Douglas Lake’s 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 square kilometers in the newly developing goldfields of Eastern Tanzania. Douglas Lake filed the Technical Report with the British Columbia Securities Commission via the System for Electronic Document Analysis and Retrieval (SEDAR).

The Technical Report was prepared by Dr. Reyno Scheepers, Ph.D., Pr.Sci.Nat., a South African based consulting geologist and a director of the Company who fulfills the requirements to be a ‘Qualified Person’ for the purposes of NI 43-101.

The Technical Report details the results of exploration activities conducted by IPP Resources, the previous holding company of the area. Extensive geophysical and geologic work was conducted over several field seasons from 2008. The work included prospecting, rock and soil sampling, and a ground magnetic survey. All geochemical analytical work was conducted by internationally accredited labs, SGS Laboratories and/or Humac Laboratories in Mwanza, Tanzania.

In the past year, the Douglas Lake Minerals team has made a strategic decision to focus exclusively on its two highly prospective gold properties – the recently purchased Handeni Gold Project and the Mkuvia Alluvial Gold Project. The 800 square kilometer Handeni property will be explored under the guidance of Dr. Reyno Scheepers and is located directly adjacent to Canaco Resources’ highly prospective Handeni Gold Project (TSX.V-CAN). The 380 square kilometer Mkuvia property is being developed by a joint-venture company run by Douglas Lake Minerals’ partner.

*****************************************

power3

Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

Parkinson’s disease (PD) is associated with a team of disorders referred to as motor system disorders, which are the result of the losing of dopamine-producing brain cells. The 4 principal symptoms of PD are generally tremor, or moving in hands, arms, legs, jaw, and face; rigidity, as well as stiffness of the limbs and trunk; bradykinesia, or slowness of motion; and postural instability, or inable equilibrium and also coordination. As these signs and symptoms become more pronounced, patients might have trouble walking, talking, or accomplishing various other tasks.

Breast cancer (malignant breast neoplasm) is normally cancer originating from breast tissue, most frequently of your inside lining of milk ducts or the lobules that offer the ducts with milk. Cancers originating from ducts these are known as ductal carcinomas; cancer originating from lobules are known as lobular carcinomas.

Alzheimer's is one among the well known form of dementia, a standard term for loss of memory along with other cerebral abilities major enough to obstruct routine. Alzheimer's disease diseases is liable for 50 to 70 percent of dementia cases.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

*****************************************

Arris Group Inc. (Nasdaq:ARRS) announced that Robert Stanzione, ARRIS Chairman & CEO, will present at the 13th Annual Needham Growth Conference at the New York Palace Hotel, New York on Tuesday, January 11, 2011 at approximately 1:30 pm Eastern.

ARRIS Group, Inc. develops manufactures, and supplies telephony, data, video, construction, rebuild, and maintenance equipment for the broadband communications industry worldwide.

*****************************************

Einstein Noah Restaurant Group, Inc. (Nasdaq:BAGL) announced that the Company will present at two investor conferences this month. On Tuesday, January 11, 2011, the Company will present at the Cowen & Co. 9th Annual Consumer Conference at The Westin New York at Times Square in New York City. The presentation will begin at 10:30 am Eastern Time. On Wednesday, January 12, 2011, the Company will present at the 13th Annual ICR XChange Conference at The St. Regis Monarch Beach Resort & Spa in Dana Point, Calif. The presentation will begin at 10:20 am Pacific Time.

Einstein Noah Restaurant Group, Inc. owns, operates, franchises, and licenses bagel specialty restaurants in the United States. As of December 29, 2009, it operated 683 restaurants in 37 states and the District of Columbia primarily under the Einstein Bros. Bagels, Noah's New York Bagels, and Manhattan Bagel brand names.

*****************************************

Glacier Bancorp Inc. (Nasdaq:GBCI) declared a quarterly dividend of $.13 per share. The dividend is payable on January 20, 2011, to owners of record on January 11, 2011.

Glacier Bancorp, Inc., a multi-bank holding company, provides commercial banking products and services in Montana, Idaho, Wyoming, Colorado, Utah, and Washington. It generates various deposit products, including regular statement savings, interest-bearing checking, money market deposit, fixed rate certificates of deposit.

****************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

drstbc